Back to Agenda
Session 16: NDA Submission, FDA Review, and Action on Applications
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Electronic Submissions
- FDA Review of Applications and Actions on Applications
- Amendments to an Unapproved Application
- Reasons Applications are not Approved
- PDUFA
Have an account?